| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
An aerobiological model of aerosol survival of different strains of Pseudomonas aeruginosa isolated from people with cystic fibrosis
|
Clifton, I.J.
|
|
2010
|
9 |
1 |
p. 64-68
5 p.
|
article
|
| 2 |
A 10-year large-scale cystic fibrosis carrier screening in the Italian population
|
Picci, Luigi
|
|
2010
|
9 |
1 |
p. 29-35
7 p.
|
article
|
| 3 |
Can Burkholderia cepacia complex be eradicated with nebulised Amiloride and TOBI®?
|
Ball, R.
|
|
2010
|
9 |
1 |
p. 73-74
2 p.
|
article
|
| 4 |
Constipation in pediatric Cystic Fibrosis patients: An underestimated medical condition
|
van der Doef, H.P.J.
|
|
2010
|
9 |
1 |
p. 59-63
5 p.
|
article
|
| 5 |
Cystic fibrosis transmembrane conductance regulator (CFTR) regulates the production of osteoprotegerin (OPG) and prostaglandin (PG) E2 in human bone
|
Le Heron, Louis
|
|
2010
|
9 |
1 |
p. 69-72
4 p.
|
article
|
| 6 |
Entry of Burkholderia organisms into respiratory epithelium: CFTR, microfilament and microtubule dependence
|
Taylor, Jane B.
|
|
2010
|
9 |
1 |
p. 36-43
8 p.
|
article
|
| 7 |
Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients
|
Hansen, C.R.
|
|
2010
|
9 |
1 |
p. 51-58
8 p.
|
article
|
| 8 |
Long-term daily high and low doses of azithromycin in children with cystic fibrosis: A randomized controlled trial
|
Kabra, S.K.
|
|
2010
|
9 |
1 |
p. 17-23
7 p.
|
article
|
| 9 |
Measuring and improving respiratory outcomes in cystic fibrosis lung disease: Opportunities and challenges to therapy
|
Zemanick, Edith T.
|
|
2010
|
9 |
1 |
p. 1-16
16 p.
|
article
|
| 10 |
Prevalence of dyslipidemia in adults with cystic fibrosis
|
Rhodes, Bronwen
|
|
2010
|
9 |
1 |
p. 24-28
5 p.
|
article
|
| 11 |
Pulmonary outcome differences in U.S. and French cystic fibrosis cohorts diagnosed through newborn screening
|
Walsh, Aimee C.
|
|
2010
|
9 |
1 |
p. 44-50
7 p.
|
article
|
Journal description